Video Library - Interview with the Innovators
Ralph V. Boccia, MD, FACP
Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
Related Items
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Clinical Validation of CancerTYPE ID
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
CancerTYPE ID in the Clinic
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
CancerTREATMENT NGS+ in the Clinic
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Managing Costs in Oncology Care
Ralph V. Boccia, MD, FACP
Video Library published on April 14, 2015 in Interview with the Innovators
Last modified: April 14, 2015
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME